| The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer RM Bremnes, T Dønnem, S Al-Saad, K Al-Shibli, S Andersen, R Sirera, ... Journal of thoracic oncology 6 (1), 209-217, 2011 | 734 | 2011 |
| The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer RM Bremnes, LT Busund, TL Kilvær, S Andersen, E Richardsen, ... Journal of Thoracic Oncology 11 (6), 789-800, 2016 | 457 | 2016 |
| The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer RM Bremnes, K Al-Shibli, T Donnem, R Sirera, S Al-Saad, S Andersen, ... Journal of Thoracic Oncology 6 (4), 824-833, 2011 | 374 | 2011 |
| Stromal CD8+ T-cell density—a promising supplement to TNM staging in non–small cell lung cancer T Donnem, SM Hald, EE Paulsen, E Richardsen, S Al-Saad, TK Kilvaer, ... Clinical Cancer Research 21 (11), 2635-2643, 2015 | 304 | 2015 |
| Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer T Donnem, TK Kilvaer, S Andersen, E Richardsen, EE Paulsen, SM Hald, ... Annals of Oncology 27 (2), 225-232, 2016 | 181 | 2016 |
| Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch‐1 and vascular endothelial growth factor‐A predicts poor survival T Donnem, S Andersen, K Al‐Shibli, S Al‐Saad, LT Busund, RM Bremnes Cancer 116 (24), 5676-5685, 2010 | 170 | 2010 |
| Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells T Donnem, S Al-Saad, K Al-Shibli, S Andersen, LT Busund, RM Bremnes Journal of Thoracic Oncology 3 (9), 963-970, 2008 | 137 | 2008 |
| Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization T Donnem, K Eklo, T Berg, SW Sorbye, K Lonvik, S Al-Saad, K Al-Shibli, ... Journal of translational medicine 9 (1), 6, 2011 | 135 | 2011 |
| MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer T Donnem, CG Fenton, K Lonvik, T Berg, K Eklo, S Andersen, H Stenvold, ... PloS one 7 (1), e29671, 2012 | 133 | 2012 |
| Prognostic value of macrophage phenotypes in resectable non–small cell lung cancer assessed by multiplex immunohistochemistry M Rakaee, LTR Busund, S Jamaly, EE Paulsen, E Richardsen, ... Neoplasia 21 (3), 282-293, 2019 | 121 | 2019 |
| Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure‐free survival in prostate cancer N Ness, S Andersen, A Valkov, Y Nordby, T Donnem, S Al‐Saad, ... The Prostate 74 (14), 1452-1461, 2014 | 121 | 2014 |
| Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer: Coexpression with vascular endothelial growth factor‐A predicts poor survival T Donnem, K Lonvik, K Eklo, T Berg, SW Sorbye, K Al‐Shibli, S Al‐Saad, ... Cancer 117 (14), 3193-3200, 2011 | 106 | 2011 |
| Assessing PD-L1 and PD-1 in Non-Small Cell Lung Cancer (NSCLC): a Novel Immunoscore Approach EE Paulsen, TK Kilvaer, MR Khanehkenari, S Al-Saad, S Andersen, ... | 94 | 2016 |
| Assessing PDL-1 and PD-1 in non–small cell lung cancer: a novel immunoscore approach EE Paulsen, TK Kilvaer, MR Khanehkenari, S Al-Saad, SM Hald, ... Clinical lung cancer 18 (2), 220-233. e8, 2017 | 93 | 2017 |
| CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases EE Paulsen, TK Kilvaer, M Rakaee, E Richardsen, SM Hald, S Andersen, ... Cancer Immunology, Immunotherapy 66 (11), 1449-1461, 2017 | 89 | 2017 |
| The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort N Ness, S Andersen, MR Khanehkenari, CV Nordbakken, A Valkov, ... Oncotarget 8 (16), 26789, 2017 | 85 | 2017 |
| Monocarboxylate transporters 1–4 in NSCLC: MCT1 is an independent prognostic marker for survival M Eilertsen, S Andersen, S Al-Saad, Y Kiselev, T Donnem, H Stenvold, ... PloS one 9 (9), e105038, 2014 | 80 | 2014 |
| High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence Y Nordby, E Richardsen, M Rakaee, N Ness, T Donnem, HRH Patel, ... Scientific reports 7, 43378, 2017 | 77 | 2017 |
| CD45RO+ Memory T Lymphocytes—a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer EE Paulsen, T Kilvaer, MR Khanehkenari, RJ Maurseth, S Al-Saad, ... Neoplasia 17 (11), 839-848, 2015 | 71 | 2015 |
| CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy SM Hald, RM Bremnes, K Al-Shibli, S Al-Saad, S Andersen, H Stenvold, ... Lung cancer 80 (2), 209-215, 2013 | 71 | 2013 |
